Loading...

SRPT SAREPTA THERAPEUTICS INC Management Changes 8-K Filing

SRPT

SRPT

SAREPTA THERAPEUTICS INC

(SRPT)

2026 8-K

CEO Retirement Announcement

Financial Results Released

Business Update

Debt Exchange Agreement

Convertible Notes Exchange

CEO Equity Grant

Financial Results Announced

Convertible Notes Exchange

Debt Exchange Agreement

Management Change

Clinical Trials

Reduction in Force

Rights Offerings

Earnings Announcement

Credit Agreement

Financial Results

Collaboration Agreement

Amendment to Incentive Plan

Financial Results

FDA Approval of ELEVIDYS

Annual Meeting Results

External Links:

On February 25, 2026, Sarepta Therapeutics, Inc. announced the retirement of its CEO, Douglas Ingram, by the end of 2026 or when a successor is appointed. The company is actively searching for his replacement.

AI Assistant

SAREPTA THERAPEUTICS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.